Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.31 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.31 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8334835 | 0.91 | GAA (0.31) | CA1CA2ACHEPTGS2HIF1A | |
| SCHEMBL8338131 | 0.89 | HIF1A (0.35) | SMN1; SMN2HIF1A | |
| SCHEMBL8339968 | 0.89 | HIF1A (0.35) | SMN1; SMN2HIF1A | |
| SCHEMBL8336029 | 0.87 | TAS1R3 (0.33) | SMN1; SMN2HIF1A | |
| SCHEMBL8336542 | 0.87 | PTGS2 (0.32) | PTGS2HIF1AAKR1C3AKR1C2 | |
| SCHEMBL8334657 | 0.86 | SMN1; SMN2 (0.34) | SMN1; SMN2HIF1A | |
| SCHEMBL8340001 | 0.86 | SMN1; SMN2 (0.36) | SMN1; SMN2HIF1ATDP1L3MBTL1 | |
| SCHEMBL8337752 | 0.85 | SMN1; SMN2 (0.35) | SMN1; SMN2HIF1ATDP1L3MBTL1 | |
| SCHEMBL8338169 | 0.84 | HIF1A (0.34) | SMN1; SMN2HIF1A | |
| SCHEMBL8336318 | 0.84 | SMPD1 (0.35) | SMN1; SMN2TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5977177-A | Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1999-11-02 | — | — | US | disclosed |
| US-5880155-A | TREATMENT OF CARDIOVASCULAR DISORDERS | HOECHST AKTIENGESELLSCHAFT (DE) | 1999-03-09 | — | — | US | disclosed |